Larson Financial Group’s Psychemedics Corporation PMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-8
Closed 961
2021
Q1
$0 Hold
8
﹤0.01% 940
2020
Q4
$0 Hold
8
﹤0.01% 870
2020
Q3
$0 Hold
8
﹤0.01% 852
2020
Q2
$0 Hold
8
﹤0.01% 773
2020
Q1
$0 Sell
8
-392
-98% -$3.3K ﹤0.01% 675
2019
Q4
$4K Hold
400
﹤0.01% 406
2019
Q3
$4K Hold
400
﹤0.01% 393
2019
Q2
$4K Hold
400
﹤0.01% 342
2019
Q1
$6K Hold
400
﹤0.01% 283
2018
Q4
$6K Buy
+400
New +$6.89K 0.01% 266

Other funds holding PMD

Larson Financial Group's PMD Position: Q2 2021 in Review

Larson Financial Group sold out of Psychemedics Corporation (PMD) in Q2 2021, closing a stake of 8 shares.

Larson Financial Group first reported a position in PMD in Q4 2018 and held it in 10 quarters. The position peaked at $6K in Q1 2019. 28 funds tracked by Wall St. Rank hold PMD as of Q2 2021.

  • Larson Financial Group reported no remaining Psychemedics Corporation position as of Q2 2021 after selling out during the quarter.
  • Larson Financial Group sold 8 Psychemedics Corporation shares in Q2 2021.
  • Larson Financial Group first reported a position in Psychemedics Corporation in Q4 2018 and held it in 10 quarters.
  • Larson Financial Group's Psychemedics Corporation position peaked at $6K in Q1 2019.
  • 28 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q2 2021.

Based on Larson Financial Group's 13F filing for Q2 2021, filed 10 Aug 2021.